Delivery Order SPE2DB22D1106-SPE2DB24FELE4
- Not listed
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract valued at $1,734.42 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Ondansetron ODT 8 mg tablets. The contract has a completion date of January 26, 2024 and was awarded on January 25, 2024. Amerisourcebergen Drug Corp is the prime contractor and does not have any major subcontractors listed. This delivery order is...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4,563,728,753 units of Ondansetron ODT 8 mg tablets. The $3,297.64 contract has a completion date of February 22, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used. This delivery order is issued under an indefinite delivery contract (IDC) valued up...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,249,283 units of the pharmaceutical product Ondansetron ODT 4 mg Tablet 30s. The award, valued at $6,719.95, has an ultimate completion date of April 12, 2024. Amerisourcebergen Drug Corp is the prime contractor and holds an indefinite delivery contract (IDC) with DLA valued up to...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply Ondansetron HCL 4 mg tablets. The $1,667.12 contract has a completion date of February 6, 2024. Amerisourcebergen Drug Corp is the prime contractor and there are no set-aside designations indicated. This delivery order is issued under a larger indefinite delivery contract (IDC) with a potential...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a for-profit pharmaceutical distribution company, to supply 4,564,118,240 units of the drug Ondansetron ODT 4 mg tablets. The $10,443.47 firm fixed price contract has an ultimate completion date of April 1, 2024. AmerisourceBergen Drug Corp is the prime contractor and no subcontractors are mentioned. This delivery order is issued under an Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of 4,564,235,087 units of Ondansetron ODT 4 mg tablets. The $4,464.67 contract has an ultimate completion date of April 11, 2024 and does not utilize any set-aside designations. AmerisourceBergen Drug Corp is the prime contractor and serves as the primary supplier of pharmaceutical products and medical supplies to...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of Ondansetron ODT 4 mg tablets. The order, valued at $3,672.70, has a completion date of February 1, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used. This delivery order is issued under a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug...
- The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, through its Corporate Office division, a firm fixed price delivery order contract worth $1,222.69 for the supply of 4,564,095,638 units of Ondansetron HCL 4 MG tablets. The contract has an ultimate completion date of March 28, 2024. Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical sourcing and distribution company Amerisourcebergen Corporation, is the prime contractor. This delivery order is part...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply Ondansetron ODT 4 mg tablets in 30-count packages. The contract has a completion date of January 30, 2024 and a potential value of $16,060.02. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is not designated as a set-aside contract. Amerisourcebergen Drug Corp...
- The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Ondansetron ODT 4 mg tablets. The contract has a potential value of $1,189.79 and a completion date of February 20, 2024. Amerisourcebergen Drug Corp is the prime contractor and operates out of its Corporate Office division in Conshohocken, Pennsylvania. This delivery order is part of a larger...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB24FELE4Delivery Order
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $5,285.74 firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., to supply 4,564,259,771 units of the pharmaceutical product Ondansetron ODT 4 mg tablets. This contract has an ultimate completion date of April 15, 2024 and was awarded on April 12, 2024. AmerisourceBergen Drug Corp is the prime contractor and is a for-profit organization. This delivery order is issued under an indefinite delivery contract (IDC) valued up to $999,999,999.00 through December 31, 2025, which serves as the primary contract vehicle for AmerisourceBergen to provide pharmaceuticals and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this contract award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.3k | 4/12/24 |